Literature DB >> 7400970

Kinetics of distribution of di-propranolol in various organs and discrete brain areas of the rat.

G Bianchetti, J L Elghozi, R Gomeni, P Meyer, P L Morselli.   

Abstract

The kinetics of distribution of di-propranolol (P) to various organs and tissues were studied in the rat after an i.v. dose of 2 mg/kg. The disposition of the drug can be adequately described by a two-compartment open model with a distribution half-life of 4.8 min, a terminal blood half-life of 63 min and an apparent volume of distribution beta of 8.5 liters/kg. Higher tissue concentrations were found to be present in heart, brain and kidney. Although the disappearance rate of P from abdominal aorta, muscles, adipose tissue and whole brain paralleled that of blood, the elimination rate constant for atria and kidney was significantly reduced suggesting a specific binding of P. After an i.v. dose of 5 mg/kg, P distributed rapidly to various brain areas following a vascularity pattern with higher concentrations in cortical areas of earlier times. An equilibrium between various brain areas was observed at 2 to 3 hr after dosing. There was a parallel decay of P concentrations in the blood and in cortical areas, whereas the elimination constants were significantly reduced for hypothealamic nuclei and the medulla (C1 and C2), suggesting again a specific binding. The data show that distribution, uptake and tissue binding of P in various peripheral organs and discrete brain areas is not a uniform process and they could give a partial explanation on the discrepancies observed clinically between the pharmacodynamics and pharmacokinetics. The data also suggest the possibility of specific P binding sites in heart, kidney and brain which could be of relevance for its mode of action.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400970

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.

Authors:  M A van Baak; J M Mooij; P M Schiffers
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Exercise-induced increments in plasma levels of propranolol and noradrenaline.

Authors:  G A Hurwitz; J G Webb; T Walle; S A Bai; H B Daniell; L Gourley; C Boyd Loadholt; T E Gaffney
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

3.  Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.

Authors:  H Harashima; Y Sawada; Y Sugiyama; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1985-08

4.  Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat.

Authors:  David Lindenbach; Corinne Y Ostock; Karen L Eskow Jaunarajs; Kristin B Dupre; Christopher J Barnum; Nirmal Bhide; Christopher Bishop
Journal:  J Pharmacol Exp Ther       Date:  2011-03-14       Impact factor: 4.030

5.  Propranolol-induced inhibition of rat brain cytoplasmic phosphatidate phosphohydrolase.

Authors:  A S Pappu; G Hauser
Journal:  Neurochem Res       Date:  1983-12       Impact factor: 3.996

6.  Centrally administered CYP2D inhibitors increase oral tramadol analgesia in rats.

Authors:  Douglas M McMillan; Ahmed A El-Sherbeni; Janielle Richards; Rachel F Tyndale
Journal:  Brain Res Bull       Date:  2020-09-11       Impact factor: 4.077

7.  The role of CYP2D in rat brain in methamphetamine-induced striatal dopamine and serotonin release and behavioral sensitization.

Authors:  Marlaina R Stocco; Ahmed A El-Sherbeni; Bin Zhao; Maria Novalen; Rachel F Tyndale
Journal:  Psychopharmacology (Berl)       Date:  2021-03-01       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.